Abstract

Prostate cancer is one of the most common malignancies among men worldwide. Early detection and accurate prognosis are critical for effective management and treatment. Biomarkers have emerged as valuable tools in the diagnosis and prognosis of prostate cancer, offering potential for more personalized and precise medical interventions. This article reviews the current and emerging biomarkers for prostate cancer, highlighting their roles in diagnosis, prognostication, and the challenges associated with their clinical implementation.